SEARCH HEALTH CONDITIONS BY ALPHABETS
Tuberculosis, Latent
Medications for Tuberculosis, Latent
Around Tuberculosis, Latent: Latent tuberculosis infection is the existence of Mycobacterium tuberculoisis within the entire body, without signs or symptoms of the disorder.
Drugs Used in the Treatment of Tuberculosis, Latent
This list of medications come in some way associated with, or found in the treating this particular condition.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| isoniazid | Rx | C | N | Y | 17 testimonials | 5.1 | |
Generic title: isoniazid systemic Brand title: Nydrazid Drug class: hydrazide derivatives For users: dose, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| rifampin | Rx | C | N | 5 testimonials | 6.5 | ||
Generic title: rifampin systemic Brand names: Rifadin, Rimactane, Rifadin IV Drug class: rifamycin derivatives For users: dose, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Rifadin | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: rifampin systemic Drug class: rifamycin derivatives For users: dose, interactions, side effects For specialists: Prescribing Information | |||||||
| Nydrazid | Rx | C | N | X | Insert inspection | 0.0 | |
Generic title: isoniazid systemic Drug class: hydrazide derivatives For users: dose, interactions, side effects | |||||||
| Rimactane | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: rifampin systemic Drug class: rifamycin derivatives For users: dose, interactions, side effects | |||||||
| pyrazinamide | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: pyrazinamide systemic Drug class: miscellaneous antituberculosis agents For users: dose, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Rifadin IV | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: rifampin systemic Drug class: rifamycin derivatives For users: dose, interactions, side effects For specialists: Prescribing Information | |||||||
| rifapentine | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: rifapentine systemic Brand title: Priftin Drug class: rifamycin derivatives For users: dose, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph | |||||||
| Priftin | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: rifapentine systemic Drug class: rifamycin derivatives For users: dose, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over The Counter |
| Off Label | This medication might not be accepted by the FDA for treating the particular condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have demonstrated an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in used in pregnant women obviously outweigh potential rewards. |
| N | FDA has not classified this medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| Inch | Has a higher potential for abuse. Has no accepted medical use in treatment in the United States. There`s just a lack of accepted safety for use under medical supervision. |
| 2 | Has a higher potential for abuse. Features a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Psychotherapy can result in acute physical or psychological dependence. |
| 3 | Has a potential for abuse less than those in programs 1 and 2 two. Features a currently accepted medical use in treatment in the United States. Psychotherapy can lead to physical dependence or high psychological dependence. |
| 4 | Has a low potential for abuse relative to those in schedule 3. It`s a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 | Has a low potential for abuse relative to those in schedule 4. Features a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Ep
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always ask your physician to be sure the information displayed on this page pertains to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
